Why Co-Diagnostics Stock Is Shooting Higher Today
Co-Diagnostics (NASDAQ: CODX), considered a coronavirus stock because of its COVID-19 testing products, was up by nearly 9% in midafternoon trading on Wednesday. That's hardly surprising, since a major pharmacy chain announced today that a test using the company's technology is now available through its digital healthcare platform.
That announcement came from Walgreens Boots Alliance (NASDAQ: WBA), which is stepping up its efforts to make coronavirus diagnostic products more readily available to its customers. Among these products is COVID-19 RT-PCR, an in-home saliva test manufactured by privately held Clinical Research Laboratory.
Image source: Getty Images.
Source Fool.com
